TGA weighs up consumer warning
THE Therapeutic Goods Administration (TGA) has confirmed it will consider labelling complementary medicines to warn consumers that the products have not been tested for efficacy.
But consumer groups have called on the government to take immediate action.
Responding to last week’s Australian National Audit Office (ANAO) review of the regulation of complementary medicines, a TGA spokesperson said the administration was “supportive of moves to inform the community that low risk, complementary medicines are not tested by the TGA for efficacy”.
The spokesperson said the TGA took “every opportunity” to publicise the process in the media.
Consumers Health Forum of Australia (CHFA) CEO Carol Bennett said it was time for the government to “bite the bullet” and “put some responsibility on the industry”.
“Why should Australian consumers not have the benefit of information